HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is headquartered in Santa Clara, California.
P/B ratio for HeartBeam, Inc. (BEAT)
P/B ratio as of 2023: 3.00
According to HeartBeam, Inc.'s latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.00. At the end of 2022 the company had a P/B ratio of 16.79.
P/B ratio history for HeartBeam, Inc. from 2003 to 2023
P/B ratio at the end of each year
| Year | P/B ratio |
|---|---|
| 2023 | 3.00 |
| 2022 | 16.79 |
| 2021 | 1.79 |
| 2020 | -123.03 |
| 2019 | -101.46 |
| 2018 | 6.88 |
| 2017 | 3.62 |
| 2016 | 4.49 |
| 2015 | 4.17 |
| 2014 | 4.17 |
| 2013 | 3.03 |
| 2012 | 0.81 |
| 2011 | 0.74 |
| 2010 | 0.84 |
| 2009 | 0.95 |
| 2008 | 3.01 |
| 2007 | -1.92 |
| 2006 | -2.59 |
| 2005 | 0.00 |
| 2004 | -18.30 |
| 2003 | 5.36 |